Use of transcriptomics in hazard identification and next generation risk assessment: A case study with clothianidin. (August 2022)

• Record Type: Journal Article
• Authors: Sprenger, Heike; Kreuzer, Katrin; Alarcan, Jimmy; Herrmann, Kristin; Buchmüller, Julia; Marx-Stoelting, Philip; Braeuning, Albert
• Is Part Of: Food and chemical toxicology. Volume 166(2022)
• Publication Date: 2022-08
• Subjects: Liver toxicity -- Pesticide -- Genotoxicity -- Clastogenicity -- HepaRG cells; Toxicology -- Periodicals; Food poisoning -- Periodicals; Food Poisoning -- Periodicals; Toxicology -- Periodicals; Toxicologie -- Périodiques; Intoxications alimentaires -- Périodiques; Food poisoning; Toxicology; Periodicals; Electronic journals; 615.9
• DOI: 10.1016/j.fct.2022.113212
• Languages: English
• ISSNs: 0278-6915

Abstract

Abstract: Toxicological risk assessment is essential in the evaluation and authorization of different classes of chemical substances. Genotoxicity and mutagenicity testing are of highest priority and rely on established in vitro systems with bacterial and mammalian cells, sometimes followed by in vivo testing using rodent animal models. Transcriptomic approaches have recently also shown their value to determine transcript signatures specific for genotoxicity. Here, we studied how transcriptomic data, in combination with in vitro tests with human cells, can be used for the identification of genotoxic properties of test compounds. To this end, we used liver samples from a 28-day oral toxicity study in rats with the pesticidal active substances imazalil, thiacloprid, and clothianidin, a neonicotinoid-type insecticide with, amongst others, known hepatotoxic properties. Transcriptomic results were bioinformatically evaluated and pointed towards a genotoxic potential of clothianidin. In vitro Comet and γH2AX assays in human HepaRG hepatoma cells, complemented by in silico analyses of mutagenicity, were conducted as follow-up experiments to check if the genotoxicity alert from the transcriptomic study is in line with results from a battery of guideline genotoxicity studies. Our results illustrate the combined use of toxicogenomics, classic toxicological data and new approach methods in risk assessment. By means of a weight-of-evidence decision, we conclude that clothianidin does most likely not pose genotoxic risks to humans. Highlights: Analysis of clothianidin genotoxicity in silico, in vitro and in vivo . Application of a toxicogenomics approach to analyze genotoxicity. Weight-of-evidence decision supports classification as "non-genotoxic".